Novavax (NVAX) stock forecast for 2023. Forecast tables and graphs.

Novavax (NVAX) stock forecast for 2023

The forecast has been updated: October 14, 2021 12:20


Novavax stock price online today

Analyst Target Price

264.2

Dividend Date

10.05.2019

Ex Dividend Date

-

Last Split Factor

1:20

Last Split Date

10.05.2019

Should you buy or sell Novavax stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Novavax stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $264.2 target price for Novavax stock stock.

Today 200 Day Moving Average is the resistance level (199.47 $).

50 Day Moving Average is the resistance level (221.93 $).




NVAX Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 194.09 176.62 212.72 16.97 %
Feb 224.37 183.98 256.00 28.13 %
Mar 278.22 231.48 318.28 27.27 %
Apr 321.62 299.43 365.04 17.97 %
May 296.53 267.17 365.03 26.81 %
Jun 219.14 200.07 244.12 18.04 %
Jul 176.41 144.12 193.87 25.66 %
Aug 169.53 143.59 196.48 26.92 %
Sep 189.87 149.43 230.88 35.28 %
Oct 168.22 157.63 200.02 21.19 %
Nov 158.13 124.92 194.18 35.67 %
Dec 155.76 137.07 167.44 18.14 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Novavax stock.


Novavax overview

Novavax Address

20 FIRSTFIELD ROAD, GAITHERSBURG, MD, US

Market Capitalization

12 351 343 000 $

EBITDA

-157 414 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-13.84

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

7.39

Trailing PE

0

Forward PE

3.57

EV To Revenue

9.03

EV To EBITDA

0

52 Week High

331.68

52 Week Low

76.59

50 Day Moving Average

221.93

200 Day Moving Average

199.47

Shares Outstanding

74484000

Shares Float

74091000

Shares Short Prior Month

6678700

Short Ratio

1.47

Percent Insiders

0.527

Percent Institutions

55.32

Novavax stock forecast for this year


Novavax stock forecast for Jan 2023.
Estimated Average Forecasted Novavax Price: 194.09. Negative monthly dynamics of the instrument is expected with 16.971% volatility is expected.

Pessimistic forecast: 176.62

Optimistic: 212.72


Novavax stock forecast for Feb 2023.
Estimated Average Forecasted Novavax Price: 224.37. Positive monthly dynamics of the instrument is expected with 28.133% volatility is expected.

Pessimistic forecast: 183.98

Optimistic: 256.00


Novavax stock forecast for Mar 2023.
Estimated Average Forecasted Novavax Price: 278.22. Positive monthly dynamics of the instrument is expected with 27.273% volatility is expected.

Pessimistic forecast: 231.48

Optimistic: 318.28


Novavax stock forecast for Apr 2023.
Estimated Average Forecasted Novavax Price: 321.62. Positive monthly dynamics of the instrument is expected with 17.973% volatility is expected.

Pessimistic forecast: 299.43

Optimistic: 365.04


Novavax stock forecast for May 2023.
Estimated Average Forecasted Novavax Price: 296.53. Negative monthly dynamics of the instrument is expected with 26.808% volatility is expected.

Pessimistic forecast: 267.17

Optimistic: 365.03


Novavax stock forecast for Jun 2023.
Estimated Average Forecasted Novavax Price: 219.14. Negative monthly dynamics of the instrument is expected with 18.043% volatility is expected.

Pessimistic forecast: 200.07

Optimistic: 244.12


Novavax stock forecast for Jul 2023.
Estimated Average Forecasted Novavax Price: 176.41. Negative monthly dynamics of the instrument is expected with 25.660% volatility is expected.

Pessimistic forecast: 144.12

Optimistic: 193.87


Novavax stock forecast for Aug 2023.
Estimated Average Forecasted Novavax Price: 169.53. Negative monthly dynamics of the instrument is expected with 26.920% volatility is expected.

Pessimistic forecast: 143.59

Optimistic: 196.48


Novavax stock forecast for Sep 2023.
Estimated Average Forecasted Novavax Price: 189.87. Positive monthly dynamics of the instrument is expected with 35.280% volatility is expected.

Pessimistic forecast: 149.43

Optimistic: 230.88


Novavax stock forecast for Oct 2023.
Estimated Average Forecasted Novavax Price: 168.22. Negative monthly dynamics of the instrument is expected with 21.194% volatility is expected.

Pessimistic forecast: 157.63

Optimistic: 200.02


Novavax stock forecast for Nov 2023.
Estimated Average Forecasted Novavax Price: 158.13. Negative monthly dynamics of the instrument is expected with 35.668% volatility is expected.

Pessimistic forecast: 124.92

Optimistic: 194.18


Novavax stock forecast for Dec 2023.
Estimated Average Forecasted Novavax Price: 155.76. Negative monthly dynamics of the instrument is expected with 18.140% volatility is expected.

Pessimistic forecast: 137.07

Optimistic: 167.44



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 116.82 (18.10.2021) -0.57 %
AbbVie Inc.
ABBV 107.45 (19.10.2021) 0.02 %
Aeterna Zentaris Inc.
AEZS 0.6051 (18.10.2021) 0.13 %
Allakos Inc.
ALLK 104.04 (18.10.2021) -3.20 %
Allogene Therapeutics, Inc.
ALLO 15.73 (18.10.2021) -4.55 %
Amgen Inc.
AMGN 203.13 (18.10.2021) -2.27 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.7 (18.10.2021) -2.78 %
Aurora Cannabis Inc.
ACB 6.92 (18.10.2021) -1.56 %
Becton Dickinson and Company
BDX 238.45 (18.10.2021) -1.12 %
Biogen Inc.
BIIB 268.13 (19.10.2021) -0.59 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 128.99 (18.10.2021) -3.46 %
BioNTech SE
BNTX 261.09 (18.10.2021) 5.41 %
bluebird bio, Inc.
BLUE 21.03 (18.10.2021) 0.62 %
Boston Scientific Corp.
BSX 42.8 (18.10.2021) -1.38 %
Bristol-Myers Squibb Company
BMY 57.59 (19.10.2021) 1.14 %
Canopy Growth Corp.
CGC 13.2 (18.10.2021) -1.12 %
Castle Biosciences, Inc.
CSTL 62.67 (18.10.2021) -1.43 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 238.98 (18.10.2021) 0.46 %
Emergent BioSolutions Inc.
EBS 50.41 (18.10.2021) -0.55 %
Exelixis, Inc.
EXEL 21.5 (19.10.2021) 0.89 %
G1 Therapeutics, Inc.
GTHX 12.52 (18.10.2021) -1.96 %
Gilead Sciences, Inc.
GILD 65.9 (18.10.2021) -2.56 %
GlaxoSmithKline plc
GSK 38.65 (18.10.2021) -0.92 %
GoodRx Holdings, Inc.
GDRX 42.06 (18.10.2021) -0.85 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 65.47 (19.10.2021) 1.38 %
Inovio Pharmaceuticals, Inc.
INO 7.13 (19.10.2021) 1.57 %
Johnson & Johnson
JNJ 163.87 (19.10.2021) 2.34 %
Medtronic plc.
MDT 120.72 (18.10.2021) -5.50 %
Merck & Co., Inc.
MRK 79.49 (19.10.2021) 3.03 %
Moderna, Inc.
MRNA 334.84 (18.10.2021) 3.28 %
Novartis AG
NVS 82.34 (18.10.2021) -1.19 %
Novavax, Inc.
NVAX 166.25 (18.10.2021) 2.66 %
ObsEva SA
OBSV 2.68 (18.10.2021) -2.19 %
OrganiGram Holdings Inc.
OGI 2.36 (19.10.2021) 6.79 %
Pfizer Inc.
PFE 41.32 (18.10.2021) -0.41 %
Regeneron Pharmaceuticals, Inc.
REGN 552.11 (19.10.2021) 1.59 %
Sanofi
SNY 48.03 (18.10.2021) -1.68 %
Schrodinger, Inc.
SDGR 53.24 (18.10.2021) -3.83 %
Senseonics Holdings, Inc.
SENS 3.29 (18.10.2021) -0.30 %
Sorrento Therapeutics, Inc.
SRNE 6.69 (18.10.2021) -2.19 %
Stryker Corp.
SYK 262.05 (18.10.2021) -1.60 %
Sundial Growers Inc.
SNDL 0.6894 (19.10.2021) 5.87 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 9.79 (18.10.2021) 1.14 %
Thermo Fisher Scientific Inc.
TMO 588.03 (18.10.2021) 0.97 %
Tilray, Inc.
TLRY 11.66 (19.10.2021) 15.79 %
UnitedHealth Group, Inc.
UNH 424.62 (18.10.2021) -0.81 %
Veeva Systems Inc.
VEEV 319.24 (19.10.2021) 2.82 %
Zomedica Corp.
ZOM 0.5117 (18.10.2021) 2.03 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.02 (19.10.2021) 3.08 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.